Skip to main content
All lobbying filings

THE VOGEL GROUP

Lobbying for FORTRESS BIOTECH INC. · Biopharma venture studio that builds, funds, and manages a portfolio of drug-dev companies

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $20,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 1
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
 Lobbying activity 1
Health Issues

Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem